OR5D13

Q-omics provides the consensus-scored OR5D13 profile across patient tissues and cancer cell-line models. OR5D13 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SCLC. Additionally, OR5D13 RNA expression shows 7 significant gene co-expression associations, with the highest sampling consensus in SCLC. Together, these results highlight SCLC as cancer lineages where OR5D13 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes OR5D13 survival associations across molecular data types. OR5D13 RNA expression shows survival associations in the most cancer types (1), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

OR5D13 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
Mutation	Kaplan–Meier	1	SCLC (6)	view →
RNA	Kaplan–Meier	1	SCLC (27)	view →

This table ranks reproducible OR5D13 RNA expression–survival associations across cancer types. High OR5D13 expression shows unfavorable associations in SCLC. The SCLC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify SCLC as the clearest survival context for OR5D13 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Tertile	All	0.055	0.653	<.001	27	view →

Pink = unfavorable, green = favorable. all 1 lineages →

OR5D13-SCLC (OS)

Explore this curve interactively →